By the 1960s, Pfizer were at their “most diversified point in [its] history” – in its own words, its interests “stretched from pills to perfume, and petrochemicals to pet products”.
Institutional investors and hedge funds own 68.36% of the company’s stock. Pfizer Inc discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States ...
Pfizer's oncology market share is modest, and its financials are weaker compared to leading competitors. High R&D spending and strong operating cash flow support potential new products and ...